How I’ve managed sun sensitivity in life with IPF, post-transplant
An increased risk of skin cancer necessitates precautions

It’s been hotter than usual here in the mid-Atlantic. Temperatures in the upper 90s, flirting with 100 F, plus high humidity made it feel like 107 to 115 F. If I had to sum it up in a single word, I’d pick “miserable.”
After my diagnosis of idiopathic pulmonary fibrosis in January 2017, I knew I’d need to make adjustments to my lifestyle. When I started taking the anti-fibrotic Esbriet (pirfenidone), I reviewed the data sheet for known side effects and anything I should avoid while taking it. I learned that sun sensitivity was a common side effect, meaning I should try to limit my exposure.
On Esbriet, I did indeed become incredibly sensitive to the sun. Exposure to direct sunlight made my skin feel like it was on fire. It was uncomfortable at best, and at times painful.
My wardrobe, which had included a lot of T-shirts, soon consisted of more pants and long-sleeve shirts. My hat collection expanded from Stetsons to include many options intended to provide sun protection. I felt like I’d become an investor in Columbia Sportswear after learning that many of the company’s products feature Omni-Shade technology, which helps protect against ultraviolet (UV) rays, and have been endorsed by the Skin Cancer Foundation.
I also learned more about sunscreen than I ever imagined. I adopted a rule: Apply and reapply often and liberally. For me, the best sunscreens had a sun protection factor (SPF) of 50 or higher, and often looked like a paste on my skin. My “top-shelf” sunscreen is SPF 70.
I took my last doses of Esbriet the day before I received my bilateral lung transplant in July 2021. That, however, did not put an end to my sun sensitivity. I was now sensitive to the sun for a different reason.
Patients who receive a solid organ transplant are at an increased risk for skin cancer, primarily because they must take immunosuppressants. While these medications help prevent rejection, they can also increase the risk of skin cancer by as much as 100-fold. In addition, patients who receive lungs or a heart tend to develop skin cancer more frequently than recipients of other solid organs.
This is one reason a dermatology appointment was part of my pre-transplant testing and screening process. Post-transplant, I continue to see a dermatologist annually for a head-to-toe skin exam. I also conduct regular self-examinations. As with many other medical issues, early detection can greatly improve health outcomes.
I no longer experience the intense burning sensation I did while taking Esbriet, but I continue to cover as much skin as possible, even on the hottest of days. As for sunscreen, I use it regularly and refresh as needed. Because moisture can reduce effectiveness, it’s especially important to reapply sunscreen when the skin gets damp, such as on humid days or after jumping into the pool.
It’s not inconvenient and is now a habit for me. When I really want to wear a T-shirt, I’ll wear a long-sleeve athletic top underneath to reduce skin exposure. To receive the gift of my donor’s lungs, I had to agree to a lifetime of medical surveillance. Anything I can do to reduce the risk of skin cancer is just one more way I can make every breath count.
Note: Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Pulmonary Fibrosis News or its parent company, Bionews, and are intended to spark discussion about issues pertaining to pulmonary fibrosis.
Leave a comment
Fill in the required fields to post. Your email address will not be published.